← back to search

Steven S. Scherer

University of Pennsylvania · US
Area of research
Cellular and Molecular Neuroscience · Neurology
Research interest
Research interests include Hereditary Neurological Disorders, Nerve injury and regeneration, Genetic Neurodegenerative Diseases, and Peripheral Neuropathies and Disorders.
h-index
80
citations
20,043
works
299
NIH funding
primary concept
email

Recent publications

Genotype and phenotype spectrum of Charcot-Marie-Tooth disease due to mutations in SORD
Brain 2025cited by 7position: middledoi
SORD-deficient rats develop a motor-predominant peripheral neuropathy unveiling novel pathophysiological insights
Brain 2024cited by 10position: middledoi
The GENESIS database and tools: A decade of discovery in Mendelian genomics
Experimental Neurology 2024cited by 5position: middledoi
Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to <i>GJB1</i> variants
Brain 2023cited by 33position: middledoi
Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints
Annals of Neurology 2023cited by 26position: middledoi
Neuropathy due to bi-allelic SH3TC2 variants: genotype-phenotype correlation and natural history
Brain 2023cited by 22position: middledoi
Knock-in mouse models for CMTX1 show a loss of function phenotype in the peripheral nervous system
Experimental Neurology 2022cited by 16position: middledoi
Mutations in <i>MYO9B</i> are associated with Charcot–Marie–Tooth disease type 2 neuropathies and isolated optic atrophy
European Journal of Neurology 2022cited by 11position: middledoi
Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes
Nature Genetics 2020cited by 174position: middledoi
Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study
Brain 2020cited by 89position: middledoi
A recessive Trim2 mutation causes an axonal neuropathy in mice
Neurobiology of Disease 2020cited by 16position: lastdoi
Variation in <i>SIPA1L2</i> is correlated with phenotype modification in Charcot– Marie– Tooth disease type 1A
Annals of Neurology 2019cited by 45position: middledoi
Modifier Gene Candidates in Charcot-Marie-Tooth Disease Type 1A: A Case-Only Genome-Wide Association Study
Journal of Neuromuscular Diseases 2019cited by 28position: middledoi
Autosomal dominant optic atrophy and cataract “plus” phenotype including axonal neuropathy
Neurology Genetics 2019cited by 15position: middledoi
Myopathy associated BAG3 mutations lead to protein aggregation by stalling Hsp70 networks
Nature Communications 2018cited by 91position: middledoi
Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2
The American Journal of Human Genetics 2018cited by 77position: middledoi
Schwann cell–derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment
Journal of Clinical Investigation 2018cited by 68position: middledoi
Prevalence and orthopedic management of foot and ankle deformities in Charcot–Marie–Tooth disease
Muscle & Nerve 2017cited by 74position: middledoi
Cross-sectional analysis of a large cohort with X-linked Charcot-Marie-Tooth disease (CMTX1)
Neurology 2017cited by 55position: middledoi
Loss of Coupling Distinguishes GJB1 Mutations Associated with CNS Manifestations of CMT1X from Those Without CNS Manifestations
Scientific Reports 2017cited by 23position: middledoi
Rare Variants in MME, Encoding Metalloprotease Neprilysin, Are Linked to Late-Onset Autosomal-Dominant Axonal Polyneuropathies
The American Journal of Human Genetics 2016cited by 59position: middledoi
<i>De novo PMP2</i>mutations in families with type 1 Charcot–Marie–Tooth disease
Brain 2016cited by 45position: lastdoi
Defects of mutant DNMT1 are linked to a spectrum of neurological disorders
Brain 2015cited by 121position: middledoi
Genotype–phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the <i>MPZ</i> gene
Brain 2015cited by 106position: middledoi
CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis
Journal of Neurology Neurosurgery & Psychiatry 2014cited by 341position: middledoi
Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2
Brain 2013cited by 181position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mary M. Reilly · National Hospital for Neurology and Neurosurgery7 papers (2014–2023)Davide Pareyson · Sydney Children’s Hospitals Network7 papers (2014–2023)Michael E. Shy · University of Iowa6 papers (2014–2023)Stephan Züchner · University of Miami6 papers (2014–2024)David N. Herrmann · OTH Regensburg6 papers (2014–2023)Joshua Burns · St. Jude Children's Research Hospital5 papers (2014–2023)Sabrina W. Yum · Children's Hospital of Philadelphia4 papers (2014–2019)Adriana Rebelo · University of Miami4 papers (2018–2024)Richard S. Finkel · Veterans Affairs Canada4 papers (2014–2023) · 3 papers (2020–2024)Thomas E. Lloyd · Johns Hopkins University3 papers (2014–2019)Matilde Laurá · National Hospital for Neurology and Neurosurgery3 papers (2014–2017)Shawna Feely · University of Colorado Denver3 papers (2014–2019)Stephan Züchner · Harvard University3 papers (2019–2023)Tiffany Grider · University of Colorado Denver2 papers (2014–2015)Giuseppe Piscosquito · Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona2 papers (2014–2015)Mario Saporta · University of Miami2 papers (2019–2024)Sindhu Ramchandren · University of Iowa2 papers (2015–2023)Carly E. Siskind · Palo Alto University2 papers (2014–2015)Rosemary Shy · University of Colorado Denver2 papers (2014–2015)